Search
Clinician Ordering Portal
On Demand Education
Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses.
Dec 2014
Next-generation sequencing of uveal melanoma for detection of genetic alterations predicting metastasis.
Apr 2019
Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?
Jan 2020
Gene expression profiling and PRAME status versus tumor-node-metastasis staging for prognostication in uveal melanoma.
Aug 2018
Am J Ophthalmol 2018;195:154–60
Independent prognostic significance of gene expression profile class and largest basal diameter of posterior uveal melanomas.
Feb 2016
Am J Ophthalmol 2016;162:20-7e1.
Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes.
Jul 2016
JAMA Ophthalmol 2016;134(7):728-33.
Do largest basal tumor diameter and the American Joint Committee on Cancer’s cancer staging influence prognostication by gene expression profiling in choroidal melanoma.
Aug 2018
Am J Ophthalmol 2018 Nov;195:83–92.
Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and 2 uveal melanomas.
Jul 2016
Oncotarget 2016;7(37): 59209-19.
Recent developments in prognostic and predictive testing in uveal melanoma.
May 2014
Curr Opin in Ophthalmol 2014;25(3):234-9.
Instrument gauge and type in uveal melanoma fine needle biopsy: implications for diagnostic yield and molecular prognostication.
Aug 2020
Am J Ophthalmol 2020; online ahead of print.
Collaborative Ocular Oncology Group Report Number 1: Prospective validation of a multi-gene prognostic assay in uveal melanoma.
Aug 2012
Ophthalmology 2012;119: 1596-1603.
An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma.
Jul 2010
J Mol Diagn 2010;12(4):461-8.